Investor Relations


Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives.

Events & Presentations


Monday April 6, 2020 at 8:00 AM EDT
Ruxolitinib Cream: Phase 3 Data in Atopic Dermatitis

FRONT >> Events > View All


Monday March 2, 2020 at 11:20 AM EST
Cowen and Company’s 40th Annual Health Care Conference

Thursday February 13, 2020 at 8:00 AM EST
Q4 2019 Incyte Corporation Earnings Conference Call

Monday January 13, 2020 at 9:00 AM PST
J. P. Morgan 38th Annual Healthcare Conference Q/A Session

FRONT >> Events > View All

Investor Contacts

Michael Booth D.Phil
Division VP, Investor Relations & Corporate Responsibility
Phone: 302.498.5914

Lauren Ayala, MBA
Senior Director, Investor Relations & Corporate Responsibility
Phone: 302.498.6141

Christine Chiou
Senior Director, Investor Relations
Phone: 302.274.4773

Copyright West LLC. Minimum 15 minutes delayed.

04. Sidebar Quicklinks